Dow Jones Top Company Headlines at 5 PM ET: Tesla Under Investigation by U.S. Regulator for Model 3 Door Release Defects | Nike ... Tesla Under Investigation by U.S. Regulator for Model 3 Door Release ...

Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...

Dynavax soared by 38.19 percent on Wednesday to close at $15.38 apiece as investors took heart from news that it was set to ...

Asian shares were mixed Thursday in thin holiday trading, with most markets in the region and elsewhere closed for Christmas.

French pharmaceutical giant Sanofi has announced plans to acquire U.S.-based biotech company Dynavax Technologies in a deal ...

The Dow Jones Industrial Average climbed 0.6% to 48,731.16, while the S&P 500 added 0.32% to close at 6,932.05.

NEW YORK (AP) — Wall Street was largely unchanged early Wednesday as markets hovered near record levels on a ...

Sanofi will pay $2.2 billion for Dynavax Techologies as it looks to add another Hepatitis B and new shingles vaccines to its portfolio.

Under the terms of the deal, Sanofi will begin a tender offer to purchase Dynavax's stock for $15.50 per share in cash. That values the biotech at roughly $2.2 billion, a premium of 39% compared to ...

Wall Street closed higher and reached more records Wednesday on a holiday-shortened trading day. The Standard & Poor’s 500 index rose 22.26 points, or 0.3%, to 6,932.05. The Dow Jones industrial ...

Dec 24 (Reuters) - Sanofi (SASY.PA) said on Wednesday it will buy U.S. biotech Dynavax Technologies (DVAX.O) for around $2.2 ...